Inoviv
@inoviv.bsky.social
Inoviv uses a novel technology platform based on targeted proteomics to support pharmaceutical companies with biomarker test development.
inoviv.com
inoviv.com
MasterKey™ v1.3 is here — now with 500+ new CNS-relevant proteins added to our 3,000+ protein catalog. From AD to ALS, build high-precision multiplexed assays for #neurological disease research and clinical trial support.
Explore the update - inoviv.com/masterkey/
#proteomics #biomarkers
Explore the update - inoviv.com/masterkey/
#proteomics #biomarkers
April 3, 2025 at 4:24 PM
MasterKey™ v1.3 is here — now with 500+ new CNS-relevant proteins added to our 3,000+ protein catalog. From AD to ALS, build high-precision multiplexed assays for #neurological disease research and clinical trial support.
Explore the update - inoviv.com/masterkey/
#proteomics #biomarkers
Explore the update - inoviv.com/masterkey/
#proteomics #biomarkers